Renal Cell Carcinoma Medications

Definition of Renal Cell Carcinoma: Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type of kidney cancer in adults

Drugs (by generic name) associated with Renal Cell Carcinoma

The following drugs and medications are in some way related to, or used in the treatment of Renal Cell Carcinoma. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-conditions

Drug Name ( View by: Brand | Generic )	Reviews	Ratings
sunitinib systemic (Pro, More...) class: multikinase inhibitors, tyrosine kinase inhibitors, VEGF/VEGFR inhibitors	1 review(s)	Rate It!	8.0
peginterferon alfa-2b systemic (Pro, More...) class: antiviral interferons	0 review(s)	Not rated - Be the first
sorafenib systemic (Pro, More...) class: multikinase inhibitors, tyrosine kinase inhibitors, VEGF/VEGFR inhibitors	0 review(s)	Not rated - Be the first
temsirolimus systemic (Pro, More...) class: miscellaneous antineoplastics, mTOR inhibitors, tyrosine kinase inhibitors	0 review(s)	Not rated - Be the first
medroxyprogesterone systemic (Pro, More...) class: contraceptives, hormones/antineoplastics, progestins	0 review(s)	Not rated - Be the first
interferon alfa-2a systemic (Pro, More...) class: antineoplastic interferons	0 review(s)	Not rated - Be the first
bevacizumab systemic (Pro, More...) class: antineoplastic monoclonal antibodies, tyrosine kinase inhibitors, VEGF/VEGFR inhibitors	0 review(s)	Not rated - Be the first
capecitabine systemic (Pro, More...) class: antimetabolites	0 review(s)	Not rated - Be the first
erlotinib systemic (Pro, More...) class: EGFR inhibitors, tyrosine kinase inhibitors	0 review(s)	Not rated - Be the first
everolimus systemic (Pro, More...) class: mTOR inhibitors, mTOR kinase inhibitors, tyrosine kinase inhibitors	0 review(s)	Not rated - Be the first
aldesleukin systemic (Pro, More...) class: miscellaneous antineoplastics	0 review(s)	Not rated - Be the first

See also...

Latest Renal Cell Carcinoma Blog Post

Sunitinib Benefit Explored in Poor-Prognosis Kidney Cancer
THURSDAY, July 16 -- The oral cancer drug sunitinib (Sutent) has shown promising results in advanced kidney cancer patients who have a poor prognosis, new research says. Previous clinical trials showed that sunitinib was effective in patients with advanced...

View all Renal Cell Carcinoma blog posts.

Renal Cell Carcinoma Support Group Questions

Ask a Question about Renal Cell Carcinoma:

Learn more about Renal Cell Carcinoma

Medical encyclopedia results for: